Sponsor of the Day:
Jerkmate
https://www.morganstanley.com/insights/podcasts/thoughts-on-the-market/china-biotech-industry-surge-jack-lin
China Biotech Industry Surge 2025 | Thoughts on the Market
Listen to Jack Lin, China Healthcare Analyst, as he discusses how China’s biotech surge is reshaping healthcare, investment and innovation worldwide.
china biotechindustrysurge2025thoughts
https://research.contrary.com/report/the-state-of-the-us-china-biotech-race
Deep Dive: The State of the US-China Biotech Race | Contrary Research
A deep dive from Contrary Research.
deep diveus chinabiotech racecontrary researchstate
https://bio.news/national-security/bio-ceo-hails-congressional-report-on-threat-of-china-dominating-biotech/
BIO CEO hails congressional NSCEB study on China biotech threat
Apr 7, 2026 - A year after a congressional panel called China’s threat to U.S. biotech leadership a national security priority, BIO's CEO urged action.
china biotechceohailscongressionalstudy
https://www.statnews.com/2026/03/31/venture-capital-moves-upstream-chase-china-biotech-deals-pre-publication/
VCs move upstream, chasing China biotech before research is public
Mar 31, 2026 - U.S. and Chinese VCs court scientists pre-publication, racing to lock up IP early as competition intensifies and China’s biotech boom accelerates.
china biotechvcsmoveupstreamchasing
https://endpoints.news/rfk-jr-says-china-is-eating-our-lunch-in-biotech-advances/
RFK Jr. says China is ‘eating our lunch’ in biotech advances
Apr 21, 2026 - HHS Secretary Robert F. Kennedy Jr. told Congress on Tuesday that 'China is eating our lunch' on new drug approvals and clinical trial starts.
rfk jr sayschinabiotechadvances
https://bio.news/national-security/bio-expert-future-of-biotech-depends-on-competing-with-china-updating-fda/
BIO expert: Future of biotech depends on China competition
Apr 7, 2026 - Ensuring a brighter future for U.S. biotech requires modernizing the FDA and addressing challenges from China, says BIO's Kelly Seagraves.
china competitionbioexpertfuturedepends
https://www.defenseone.com/ideas/2019/08/chinas-military-pursuing-biotech/159167/
Weaponizing Biotech: How China's Military Is Preparing for a 'New Domain of Warfare' - Defense One
Jan 14, 2026 - Under Beijing's civil-military fusion strategy, the PLA is sponsoring research on gene editing, human performance enhancement, and more.
new domaindefense oneweaponizingbiotechchina